Evaluation of a formulary switch from conjugated to esterified estrogens in a managed care setting

Medical Care

Volumn 38, Issue 9, 2000, Pages 970-975

  Andrade, Susan E ^a,b   Gurwitz, Jerry H ^a   Cernieux, Jackie ^a   Fish, Leslie S ^c  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF RHODE ISLAND   (United States)

^c Fallon Clinic   (United States)

Author keywords

Estrogens; Formulary; Health service utilization

Indexed keywords

CONJUGATED ESTROGEN; ESTER; ESTROGEN;

ADULT; AMBULATORY CARE; ARTICLE; COHORT ANALYSIS; COST CONTROL; ECONOMICS; ESTERIFICATION; ESTROGEN THERAPY; EVALUATION; FEMALE; HEALTH MAINTENANCE ORGANIZATION; HUMAN; METHODOLOGY; MIDDLE AGED; PUBLICATION; RETROSPECTIVE STUDY; TREATMENT OUTCOME; UNITED STATES; UTILIZATION REVIEW;

ADULT; AMBULATORY CARE; COHORT STUDIES; COST CONTROL; ESTERIFICATION; ESTERS; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; ESTROGENS, CONJUGATED (USP); EVALUATION STUDIES; FEMALE; FORMULARIES; HEALTH MAINTENANCE ORGANIZATIONS; HUMANS; MASSACHUSETTS; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0034267299     PISSN: 00257079     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005650-200009000-00010     Document Type: Article

References (12)

1. Korman L, Borysiuk L. Replacing lovastatin with pravastatin: Effect on serum lipids and costs. Am J Health Syst Pharm 1995;52:1078-1082.
2. Stock AJ, Kofoed L. Therapeutic interchange of fluoxetine and sertraline: Experience in the clinical setting. Am J Hosp Pharm 1994;51:2279-2281.
3. Briscoe TA, Dearing CJ. Clinical and economic effects of replacing enalapril with benazepril in hypertensive patients. Am J Health Syst Pharm 1996;53:2191-2193.
4. Nadel HL. Formulary conversion from glipizide to glyburide: A cost-minimization analysis. Hosp Pharm 1995;30:467-469, 472-474.
5. Lindgren-Furmaga EM, Schuna AA, Wolff NL, Goodfriend TL. Cost of switching hypertensive patients from enalapril maleate to lisinopril. Am J Hosp Pharm 1991;48:276-279.
6. Baluch WM, Gardner JS, Krauss RH, Scholes D. Therapeutic interchange of conjugated and esterified estrogens in a managed care organization. Am J Health Syst Pharm 1999;56:537-542.
7. Belchetz PE. Hormonal treatment of postmenopausal women. N Engl J Med 1994;330:1062-1071.
8. Evans MP, Fleming KC, Evans JM. Hormone replacement therapy: Management of common problems. Mayo Clin Proc 1995;70:800-805.
9. Kalbfleisch JD, Prentice RL. The statistical analysis of failure time data. New York, NY: John Wiley; 1980.
10. Gardner J, Scholes D, Baluch W, Krauss R. Acceptability of a substitution of estrogen replacement therapy to women enrolled in a health maintenance organization. J Women's Health 1998;7:1027-1031.
11. Drug topics red book. Montvale, NJ: Medical Economics Books; 1995.
12. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women: Heart and Estrogen/Progestin Replacement Study (HERS) Research Group. JAMA 1998;280:605-613.